Immunovia announces the financial calendar for financial year 2023
LUND (SWEDEN) – Immunovia, a diagnostic company with the vision to revolutionize blood-based diagnostics and survival rates for patients with cancer, announces its financial calendar for 2023 and 2024. February 9, 2023 Year-end report 2022April 25, 2023 Q1 2023August 24, 2023 Q2 2023November 9, 2023 Q3 2023February 21, 2024 Year-end report 2023 The Annual General Meeting will be held on April 27, 2023. For more information, please contact:Karin Almqvist LiwendahlCFOkain.almqvist.liwendahl@immunovia.com+46 70 911 56 08 About Immunovia Immunovia